AB Science S.A. – LSE:0Q77.L
AB Science S.A. stock price today
AB Science S.A. stock price monthly change
AB Science S.A. stock price quarterly change
AB Science S.A. stock price yearly change
AB Science S.A. key metrics
Market Cap | 53.60M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.31 |
Revenue | 1.45M |
EBITDA | -20.19M |
Income | -15.07M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -1388.08% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAB Science S.A. stock price history
AB Science S.A. stock forecast
AB Science S.A. financial statements
| Mar 2023 | 224K | -5.20M | -2323.88% |
|---|---|---|---|
| Jun 2023 | 448K | -10.41M | -2323.88% |
| Sep 2023 | 261K | 181.5K | 69.54% |
| Dec 2023 | 522K | 363K | 69.54% |
| 2025 | 1.1M | -18.37M | -1670.55% |
|---|---|---|---|
| 2026 | 1.19M | -19.36M | -1627.67% |
Analysts Price target
Financials & Ratios estimates
| Mar 2023 | 33198000 | 52.42M | 157.91% |
|---|---|---|---|
| Jun 2023 | 33198000 | 52.42M | 157.91% |
| Sep 2023 | 0 | 0 | |
| Dec 2023 | 25499000 | 46.50M | 182.39% |
| Mar 2023 | -4.65M | -122.5K | 8.53M |
|---|---|---|---|
| Jun 2023 | -9.36M | -185K | 17.06M |
| Sep 2023 | 0 | 0 | 0 |
| Dec 2023 | -7.77M | -160K | -792K |
AB Science S.A. alternative data
| Aug 2023 | 103 |
|---|---|
| Sep 2023 | 103 |
| Oct 2023 | 103 |
| Nov 2023 | 89 |
| Dec 2023 | 89 |
| Jan 2024 | 89 |
| Feb 2024 | 89 |
| Mar 2024 | 89 |
| Apr 2024 | 89 |
| May 2024 | 89 |
| Jun 2024 | 89 |
| Jul 2024 | 51 |
AB Science S.A. other data
| Insider | Compensation |
|---|---|
Mr. Alain Moussy Co-Founder, Chairman, Pres, Chief Executive Officer & Scientific Director | $482,000 |
Mr. Denis Gicquel Head of Pharmaceutical Devel. | $95,000 |
Mr. Antonello CERVONE Head of Data Management & IT Director | |
Mr. Laurent Guy MBA Chief Financial Officer | |
Ms. Edita DOLIMIER Head of Clinical Devel. | |
Mr. Christian FASSOTTE Global Chief Medical Officer | |
Ms. Catherine MARLE Head of Clinical Operations | |
Ms. Catherine ARGILLIER Head of Quality Assurance | |
Mr. Harshad KULKARNI Head of Statistics | |
| Mr. Alexis BERNARD Head of Veterinary Sales |
-
What's the price of AB Science S.A. stock today?
One share of AB Science S.A. stock can currently be purchased for approximately $12.25.
-
When is AB Science S.A.'s next earnings date?
Unfortunately, AB Science S.A.'s (0Q77.L) next earnings date is currently unknown.
-
Does AB Science S.A. pay dividends?
No, AB Science S.A. does not pay dividends.
-
How much money does AB Science S.A. make?
AB Science S.A. has a market capitalization of 53.60M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.25% to 970K US dollars.
-
What is AB Science S.A.'s stock symbol?
AB Science S.A. is traded on the LSE under the ticker symbol "0Q77.L".
-
What is AB Science S.A.'s primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of AB Science S.A.?
Shares of AB Science S.A. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are AB Science S.A.'s key executives?
AB Science S.A.'s management team includes the following people:
- Mr. Alain Moussy Co-Founder, Chairman, Pres, Chief Executive Officer & Scientific Director()
- Mr. Denis Gicquel Head of Pharmaceutical Devel.()
- Mr. Antonello CERVONE Head of Data Management & IT Director
- Mr. Laurent Guy MBA Chief Financial Officer
- Ms. Edita DOLIMIER Head of Clinical Devel.
- Mr. Christian FASSOTTE Global Chief Medical Officer
- Ms. Catherine MARLE Head of Clinical Operations
- Ms. Catherine ARGILLIER Head of Quality Assurance
- Mr. Harshad KULKARNI Head of Statistics
- Mr. Alexis BERNARD Head of Veterinary Sales
-
Is AB Science S.A. founder-led company?
Yes, AB Science S.A. is a company led by its founder Mr. Alain Moussy.
-
How many employees does AB Science S.A. have?
As Jul 2024, AB Science S.A. employs 51 workers, which is 43% less then previous month and 43% less then previous quarter.
-
When AB Science S.A. went public?
AB Science S.A. is publicly traded company for more then 12 years since IPO on 19 Oct 2012.
-
What is AB Science S.A.'s official website?
The official website for AB Science S.A. is ab-science.com.
-
How can i contact AB Science S.A.?
AB Science S.A. can be reached via phone at +33 1 47 20 00 14.
AB Science S.A. company profile:
AB Science S.A.
ab-science.comLSE
40
Medical - Pharmaceuticals
Healthcare
AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19. The company also develops AB8939, synthetic microtubule destabilizer for the treatment of acute myeloid leukemia; and AB20001, which is in Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. It markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.
Paris, 75008
:
ISIN: FR0010557264
:
